Abstract

Precise quantification of cellular potential of stem cells, such as human bone marrow–derived mesenchymal stem cells (hBMSCs), is important for achieving stable and effective outcomes in clinical stem cell therapy. Here, we report a method for image-based prediction of the multiple differentiation potentials of hBMSCs. This method has four major advantages: (1) the cells used for potential prediction are fully intact, and therefore directly usable for clinical applications; (2) predictions of potentials are generated before differentiation cultures are initiated; (3) prediction of multiple potentials can be provided simultaneously for each sample; and (4) predictions of potentials yield quantitative values that correlate strongly with the experimental data. Our results show that the collapse of hBMSC differentiation potentials, triggered by in vitro expansion, can be quantitatively predicted far in advance by predicting multiple potentials, multi-lineage differentiation potentials (osteogenic, adipogenic, and chondrogenic) and population doubling potential using morphological features apparent during the first 4 days of expansion culture. In order to understand how such morphological features can be effective for advance predictions, we measured gene-expression profiles of the same early undifferentiated cells. Both senescence-related genes (p16 and p21) and cytoskeleton-related genes (PTK2, CD146, and CD49) already correlated to the decrease of potentials at this stage. To objectively compare the performance of morphology and gene expression for such early prediction, we tested a range of models using various combinations of features. Such comparison of predictive performances revealed that morphological features performed better overall than gene-expression profiles, balancing the predictive accuracy with the effort required for model construction. This benchmark list of various prediction models not only identifies the best morphological feature conversion method for objective potential prediction, but should also allow clinicians to choose the most practical morphology-based prediction method for their own purposes.

Highlights

  • The application of recent advances in cell technologies in regenerative medicine holds great promise for revolutionizing conventional medical therapies [1]

  • The PRE group was subjected to phase-contrast microscopic image acquisition (4 days, 24-h intervals), and the DIFF samples were differentiated into three mesenchymal lineages

  • Comparison of performances of prediction models to achieve the most balanced performance In our previous study, we found that time courses of morphological features of cultured human bone marrow–derived mesenchymal stem cells (hBMSCs) were informative in the construction of computational models aimed at forecasting future osteogenic differentiation [17]

Read more

Summary

Introduction

The application of recent advances in cell technologies in regenerative medicine holds great promise for revolutionizing conventional medical therapies [1]. The lack of assessment technology for quantitatively evaluating cell quality, in particular for revealing both the current properties and the future potentials of intact cells, is a technical obstacle to the development of quality-assured cellular products for medical use [2,3]. Conventional methods for cellular assessment using standard techniques of molecular biology are incompatible with satisfying clinical requirements, because these methods damage cultured cells. Many high-content image-analysis methodologies based on imaging and image-processing technologies, especially those focused on fluorescently labeled images, have contributed to advances in drug discoveries [7,8,9,10]. To fulfill the clinical requirements for producing intact cells for therapies, wider use of cell-morphology analysis methodologies that focus on label-free images should be encouraged

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call